Document is current
Any future updates will be listed below
-
Authors
Schmauck-Medina, Tomas https://orcid.org/0000-0003-4618-0628
Lautrup, Sofie
Di Francesco, Andrea
Mitchell, Sarah J. https://orcid.org/0000-0002-4027-3754
Clemmensen, Christoffer
Partridge, Linda
Roth, George S.
Anderson, Rozalyn M. https://orcid.org/0000-0002-0864-7998
Mattison, Julie A.
de Cabo, Rafael https://orcid.org/0000-0003-2830-5693
Speakman, John R. https://orcid.org/0000-0002-2457-1823
Richardson, Arlan
Ingram, Donald K.
Weindruch, Richard
Mattson, Mark P. https://orcid.org/0009-0000-5542-5565
Fang, Evandro F. https://orcid.org/0000-0003-0355-7202
- License Information
-
More Information
Article History
Received: 12 August 2025
Accepted: 9 February 2026
First Online: 6 March 2026
Competing interests
: E.F.F. is a co-owner of Fang-S Consultation AS (organization no. 931 410 717) and NO-Age AS (organization no. 933 219 127). E.F.F. has a material transfer agreement with LMITO Therapeutics (South Korea), a CRADA arrangement with ChromaDex (USA), a commercialization agreement with Molecule AG/VITADAO, and material transfer agreements with GeneHarbor (Hong Kong) Biotechnologies Limited and Hong Kong Longevity Science Laboratory (Hong Kong). E.F.F. is a consultant to MindRank AI (China), NYO3 (Norway), AgeLab (Vitality Nordic AS, Norway) and Hong Kong Longevity Science Laboratory (Hong Kong). D.K.I. and G.S.R. are founders and Chief Scientific Officers for GeroScience (USA) and Prolongevity Technologies (USA). D.K.I. is Chief Scientific Officer for Functional Longevity Labs (USA). C.C. is a cofounder of Ousia Pharma, a biotech company developing therapeutics for the treatment of obesity. M.P.M. is the author of and receives royalties from The Intermittent Fasting Revolution. A.D.F. is employed by Calico Life Sciences. The remaining authors declare no competing interests.
